pravastatin has been researched along with Hypertriglyceridemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornejo-Uixeda, S; Escoin-Pérez, C; Hernandez-Lorente, E | 1 |
| Beck, B; Donner, D; du Toit, EF; Headrick, JP; Oi, M; Peart, J; Wendt, L | 1 |
| Flores-Le Roux, JA; Pedro-Botet, J | 1 |
| Hosoi, T; Ito, H; Kazama, H; Okazaki, M; Orimo, H; Usui, S | 1 |
| Aeschlimann, SE; Bellehumeur, JL; Korcarz, CE; Mays, ME; Merwood, MA; Sosman, JM; Stein, JH; Underbakke, GL | 1 |
| Chen, Y; Kohno, M; Kosaka, H; Mizukawa, M; Ohmori, K; Shinomiya, K; Yoshida, J; Zeng, Y; Zhang, L | 1 |
| Harris, WS; Nelson, J; O'Keefe, JH; Windsor, SL | 1 |
| Aoki, I; Aoki, N; Homori, M; Ishikawa, K; Kawai, Y; Kawano, K; Maki, A; Shimoyama, K; Yamamoto, M; Yanagisawa, A | 1 |
| Grundy, SM | 1 |
| Lane, M; Laskarzewski, P; Stein, EA | 1 |
| Kesäniemi, YA | 1 |
| Cicco, G; Pirrelli, A; Stingi, GD; Tarallo, MS; van der Kleij, AJ | 1 |
| Adams-Huet, B; Balis, D; Devaraj, S; Grundy, SM; Jialal, I; Stein, D | 1 |
| Ambrosio, G; Chiariello, M; Lepore, S; Napoli, C | 1 |
4 review(s) available for pravastatin and Hypertriglyceridemia
| Article | Year |
|---|---|
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
Topics: Cholesterol, HDL; Cholesterol, VLDL; Clinical Trials as Topic; Consensus Development Conferences as Topic; Coronary Disease; Drug Therapy, Combination; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Triglycerides; Weight Loss | 1998 |
Comparison of statins in hypertriglyceridemia.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Clinical Trials as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides | 1998 |
Serum triglycerides and clinical benefit in lipid-lowering trials.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, LDL; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Estrogen Replacement Therapy; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Myocardial Infarction; Myocardial Ischemia; Postmenopause; Pravastatin; Risk Factors; Simvastatin; Triglycerides | 1998 |
[Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
Topics: Aged; Drug Evaluation; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Pravastatin | 1992 |
5 trial(s) available for pravastatin and Hypertriglyceridemia
| Article | Year |
|---|---|
Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes.
Topics: Aged; Aged, 80 and over; Bezafibrate; Cholesterol; Chromatography, High Pressure Liquid; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Triglycerides | 2003 |
Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors.
Topics: Adult; Brachial Artery; Cholesterol; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Lipoproteins; Male; Pravastatin; Reverse Transcriptase Inhibitors; Triglycerides; Ultrasonography; Vasodilation | 2004 |
Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia.
Topics: Adult; Apolipoprotein A-I; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Eating; Humans; Hypertriglyceridemia; Lipids; Magnesium; Niacin; Pravastatin; Risk Factors; Triglycerides | 1995 |
Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.
Topics: Atorvastatin; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertriglyceridemia; Interleukin-6; Male; Middle Aged; Pravastatin; Pyrroles; Receptors, Interleukin-6; Simvastatin; Treatment Outcome; Triglycerides | 2001 |
[Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
Topics: Aged; Drug Evaluation; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Pravastatin | 1992 |
6 other study(ies) available for pravastatin and Hypertriglyceridemia
| Article | Year |
|---|---|
Capecitabine-induced pancreatitits.
Topics: Abdomen, Acute; Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Oxaliplatin; Pancreatitis; Pravastatin; Sigmoid Neoplasms | 2018 |
Pravastatin improves risk factors but not ischaemic tolerance in obese rats.
Topics: Animals; Blood Glucose; Body Weight; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Insulin Resistance; Lipid Peroxidation; Male; Mitochondria; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Obesity; Pravastatin; Rats; Rats, Wistar; Risk Factors | 2018 |
[Efficacy studies].
Topics: Cardiovascular Diseases; Cholesterol, HDL; Drug Combinations; Dyslipidemias; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Pravastatin; Risk Factors | 2014 |
Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes.
Topics: Adiponectin; Adipose Tissue; Animals; Anticholesteremic Agents; Atorvastatin; Chemokine CCL2; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Glucose; Heptanoic Acids; Hypertriglyceridemia; Insulin Resistance; Leptin; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Pyrroles; Rats; Rats, Long-Evans; Rats, Mutant Strains; RNA, Messenger; Transforming Growth Factor beta1; Ventricular Dysfunction, Left | 2007 |
Platelet-dependent thrombin generation in patients with hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Blood Coagulation; Blood Platelets; Confounding Factors, Epidemiologic; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Lipoprotein(a); Male; Middle Aged; Phospholipids; Platelet Aggregation; Pravastatin; Prostaglandins; Thrombin | 1997 |
Laser-assisted optical rotational red cell analyzer (LORCA) in clinical practice. Hemorheological kinetics and tissue oxygenation.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Calcium Channel Blockers; Erythrocytes; Female; Hemorheology; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Kinetics; Lasers; Male; Middle Aged; Oxygen; Pravastatin | 1999 |